Roadside Oral-Fluid Drug Testing in New Zealand: What Medicinal Cannabis Patients Need to Know
How the oral-fluid testing procedure works, in plain English, for prescribed patients.
New Zealand Police can carry out roadside oral-fluid (saliva) drug testing. The substances covered by testing can include THC, which is present in many prescribed medicinal cannabis products.
This guide explains the general procedure so it is less unfamiliar if you ever encounter it. It is informational only and is not legal advice.
A lawful testing requirement must be complied with
Where an enforcement officer lawfully requires a driver to undergo an oral-fluid test, the driver must comply without delay. Holding a prescription for medicinal cannabis does not create an exemption from a lawful testing requirement.
Screening tests and laboratory analysis are different
There are two distinct stages, and they answer different questions.
- Screening tests are carried out at the roadside using an approved oral-fluid screening device. A first positive screening test can be followed by a second screening test, which is also carried out without delay.
- Laboratory analysis is carried out later by an approved laboratory on a sample taken at the roadside. It is a more precise analysis than a roadside screening result.
A screening result is an indication produced at the roadside. It is not the same as a laboratory result, and the two stages should not be treated as interchangeable.
How a sample is collected
Collection is straightforward. Under the Land Transport (Oral Fluid Samples) Regulations 2025, the officer gives the person the collection pad and explains how to use it. The person then uses the pad themselves to collect oral fluid from their own mouth, following those instructions.
Samples are handled so that they can be identified and shown not to have been interfered with. That includes sealing the sample in a tamper-evident way and labelling it before it is sent for analysis by an approved laboratory.
Private analysis
The law provides for a person to have an additional sample analysed independently. Where the statutory 10-minute opportunity to elect an additional sample for private analysis applies, the person is given that opportunity at the time, and it is a short window — it is not something that can be revisited later.
In plain terms, private analysis means an additional sample is retained so that it can be analysed by an independent laboratory at the person's own arrangement, alongside the official analysis.
Not being able to produce saliva is not the same as refusing
Some people find it difficult to produce sufficient oral fluid, for example because of dry mouth, which is a common side effect of a number of medicines. Being unable to produce a sufficient sample is not, on its own, automatically a refusal.
Refusing or failing to undergo a test when lawfully required is a separate matter. If you are having difficulty producing a sample, saying so clearly at the time is sensible.
Infringement consequences
The applicable infringement consequence for the relevant oral-fluid infringement offence is a $400 infringement fee and 75 demerit points. Where the matter is dealt with by the court rather than by infringement notice, a maximum fine of $500 applies.
The 12-hour driving prohibition
Following two positive screening tests, or in the specified refusal or failure situations, an officer may prohibit the person from driving for 12 hours. This is a road-safety measure applied at the time, and it applies regardless of what any later laboratory analysis shows.
This statutory 12-hour prohibition is a Police enforcement measure. It is not related to DriveClear's Personal Reference Period, which is simply a user-chosen recording window in the app. The two are unrelated concepts even though both can involve a 12-hour figure.
Prescribed medicinal cannabis and the medical defence
New Zealand law provides a statutory prescription defence for applicable oral-fluid offences where the statutory requirements are met. Broadly, those requirements include holding a current and valid prescription for the medicine, and complying with the applicable instructions given by the health practitioner or the drug manufacturer.
The defence is set out in section 64 of the Land Transport Act 1998. It is not an exemption from testing: the test still happens, and the defence is about what follows.
How DriveClear can help
DriveClear creates a contemporaneous record of medicinal cannabis intake and builds a treatment timeline from it — what you recorded taking, and when you recorded taking it.
Where timing forms part of the applicable instructions, that record can provide evidence relevant to establishing when the medicine was recorded as taken, and whether the recorded timeline is consistent with those instructions.
DriveClear does not measure impairment, does not predict test results, and does not guarantee that any statutory defence will succeed.
- A lawful oral-fluid testing requirement must be complied with without delay.
- Roadside screening and approved laboratory analysis are two different stages.
- The officer gives you the collection pad and explains how to use it.
- Inability to produce sufficient saliva is not automatically a refusal.
- Two positive screening tests can lead to a 12-hour driving prohibition — unrelated to DriveClear's Personal Reference Period.
- A prescription is not an exemption from testing.
Primary sources
- Land Transport Act 1998 (current version)
- Land Transport (Drug Driving) Amendment Act 2025
- Land Transport (Oral Fluid Samples) Regulations 2025
Continue learning
A plain-English explanation of the statutory medical defence in section 64 of the Land Transport Act 1998, and why prescriptions, instructions and timing can all matter.
A simple checklist of the medicinal cannabis records worth keeping access to, and how each one differs.
What roadside drug testing is, why treatment records matter, and what DriveClear can and cannot tell you.
A plain-English explanation of why a drug test detecting THC does not tell you how impaired someone is, if at all.